Bayer to Develop Hemophilia Gene Therapy Treatment

Dimension Therapeutics, a Cambridge biotechnology startup, has struck a deal worth up to $252 million with the pharmaceutical giant Bayer HealthCare to develop a gene therapy to treat hemophilia, a rare disease that prevents blood from clotting.The goal of the prospective treatment, which is not yet in clinical trials, is to repair a faulty gene […]

Dear Addy: Educating the Emergency Room

Dear Addy,We went out of town for vacation and I had to take my son to the ER for a bleed due. Unfortunately, none of the doctors were familiar with hemophilia. I knew more than they did. Instead of comforting my son, I spent my time educating doctors. Is there something I can do better […]